EP 031:31

“GLP-2” and “GLP-3”, decoded

There is no hormone called GLP-3. The nicknames count how many body signals a medicine copies.

Transcript and sources
  1. There's no hormone called GLP-3. So what is everyone talking about?
  2. Those names are counting something real: the body signals a medicine copies. Learn to count them, and the whole family makes sense.
  3. Start with the real one. GLP-1 is a hormone your gut sends after a meal. It helps release insulin when blood sugar is high, and tells your brain you've had enough.
  4. Most of these medicines copy only GLP-1: semaglutide, in Ozempic and Wegovy; liraglutide; dulaglutide; and a new pill, orforglipron.
  5. Tirzepatide, in Mounjaro and Zepbound, copies two signals: GLP-1 and GIP. Online, that earns it the nickname GLP-2. But the real GLP-2 is a different hormone, one that helps the gut lining grow.
  6. Retatrutide copies three: GLP-1, GIP, and glucagon. That's the GLP-3. Its maker calls the name inaccurate, and it's still in trials, not approved.
  7. So skip the numbers and count the signals: GLP-1 alone, plus GIP, plus glucagon, or plus amylin, a fullness signal from the pancreas.
  8. And if someone sells a GLP-3 labelled for research, it is not approved medicine. The FDA has sent warning letters to sellers using these names.
  9. Every medicine, and the evidence behind it, is at peplexicon.com.

Sources

  1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007
  2. Ozempic (semaglutide) prescribing information, DailyMed
  3. Wegovy (semaglutide) injection and tablets prescribing information, DailyMed
  4. Foundayo (orforglipron) prescribing information, DailyMed
  5. Mounjaro (tirzepatide) prescribing information, DailyMed
  6. Zepbound (tirzepatide) prescribing information, DailyMed
  7. Gattex (teduglutide) prescribing information, DailyMed
  8. Eli Lilly: What to know about retatrutide
  9. Eli Lilly: retatrutide TRIUMPH-1 phase 3 topline results, May 21, 2026 (not yet peer reviewed)
  10. FDA warning letter to Gram Peptides (tirzepatide sold as “GLP-2 peptide”), Mar 31, 2026
  11. FDA warning letter to Mile High Compounds (“GLP-2 TRZ”, “GLP-3 RT”), Mar 31, 2026
Go deeperRead the GLP-1 guide